{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Concentration": ".*",
      "Species": ".*",
      "TimePoint": ".*"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Farah Humayun",
      "contact": "farah.humayun@scai-extern.fraunhofer.de",
      "description": "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia.",
      "licenses": "MIT License",
      "name": "heme_22954673.bel",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "HM": ".*",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "path": "heme_22954673.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "As can be observed in Fig. 1, heme has a potent chemotactic activity on VSMC (Fig. 1A), and is also a potent inducer of VSMC proliferation (Fig. 1B).",
      "key": "d561b7ce438c305ea23456514c2366a5",
      "line": 94,
      "relation": "increases",
      "source": 5,
      "target": 9
    },
    {
      "annotations": {
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Accordingly, Fig. 2A shows that heme (10 mM) induces a strong ROS production after 1 h of incubation with VSMC.",
      "key": "ebade5916f2750948b906b45087e5303",
      "line": 111,
      "relation": "increases",
      "source": 5,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Corroborating recent studies that showed heme as an inductor of ROS generation via NADPHox in neutrophils, macrophages and in VSMC [7,8,19], the pretreatment of cells with DPI (10 mM), a NADPHox inhibitor [20], prevented heme-induced ROS production in A7r5 VSMC (Fig. 2A).",
      "key": "2ebe39ee685958749bef4cad0c953d23",
      "line": 121,
      "relation": "increases",
      "source": 5,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "On the other hand, heme induced HO-1 expression in VSMC (Suppl. Fig. 2).",
      "key": "e88f0862e92940b0dcdc698418550c74",
      "line": 157,
      "relation": "increases",
      "source": 5,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Among the redox-sensitive molecules, ERK-2, a member of MAPK family, is of crucial importance to VSMC proliferation and migration [21].",
      "key": "f5c811a3ea7814f45856d2bbcc43d01f",
      "line": 140,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 12
    },
    {
      "annotations": {
        "Concentration": {
          "100 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Heme effects were shown to be redoxsensitive, since the antioxidant Trolox\u0003 (100 mM) abrogated heme-induced VSMC migration and proliferation (Fig. 1C,D).",
      "key": "9cc33f53f8a6efbba5bbbe00e838e988",
      "line": 102,
      "relation": "decreases",
      "source": 3,
      "target": 9
    },
    {
      "annotations": {
        "Concentration": {
          "100 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Heme effects were shown to be redoxsensitive, since the antioxidant Trolox\u0003 (100 mM) abrogated heme-induced VSMC migration and proliferation (Fig. 1C,D).",
      "key": "f4f546158ea5aa0376ec66cc1a6f400e",
      "line": 103,
      "relation": "decreases",
      "source": 3,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Among the redox-sensitive molecules, ERK-2, a member of MAPK family, is of crucial importance to VSMC proliferation and migration [21].",
      "key": "cc428c755146079500a6072df6b9579f",
      "line": 141,
      "relation": "positiveCorrelation",
      "source": 8,
      "target": 12
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Corroborating recent studies that showed heme as an inductor of ROS generation via NADPHox in neutrophils, macrophages and in VSMC [7,8,19], the pretreatment of cells with DPI (10 mM), a NADPHox inhibitor [20], prevented heme-induced ROS production in A7r5 VSMC (Fig. 2A).",
      "key": "a60e9bf9ba81b6d858a28c1e3c46eea1",
      "line": 123,
      "relation": "decreases",
      "source": 4,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Moreover, DPI strongly inhibited heme-induced VSMC migration (Fig. 2B) and blunted the proliferative capability of heme-treated VSMC that reached levels below the controls. (Fig. 2C), indicating that heme effects on VSMC migration and proliferation are modulated by NADPHox.",
      "key": "2fb626d34ffecb8e06d7add66872981c",
      "line": 132,
      "relation": "decreases",
      "source": 4,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Moreover, DPI strongly inhibited heme-induced VSMC migration (Fig. 2B) and blunted the proliferative capability of heme-treated VSMC that reached levels below the controls. (Fig. 2C), indicating that heme effects on VSMC migration and proliferation are modulated by NADPHox.",
      "key": "114d664488fa244d5bb3fe93d15345f0",
      "line": 133,
      "relation": "decreases",
      "source": 4,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Among the redox-sensitive molecules, ERK-2, a member of MAPK family, is of crucial importance to VSMC proliferation and migration [21].",
      "key": "ac592774294753f4dabb6721ecbff62d",
      "line": 140,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Among the redox-sensitive molecules, ERK-2, a member of MAPK family, is of crucial importance to VSMC proliferation and migration [21].",
      "key": "0790b6b7f961e4264b4103112178eab7",
      "line": 141,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "In VSMC pretreated with the ERK-2 inhibitor PD98059 (10 mM), migration induced by heme was partially inhibited (Fig. 3A) and heme proliferative effect on VSMC was impaired (Fig. 3B).",
      "key": "f17c8a73d455b763ed596809b38634f1",
      "line": 150,
      "relation": "decreases",
      "source": 0,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "In VSMC pretreated with the ERK-2 inhibitor PD98059 (10 mM), migration induced by heme was partially inhibited (Fig. 3A) and heme proliferative effect on VSMC was impaired (Fig. 3B).",
      "key": "54ee15a426b4cdc3971baa3377dbe21c",
      "line": 151,
      "relation": "decreases",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Additionally, it was observed that inhibition of HO-1 by ZnPP induced a further increase in hemeinduced ROS production (Fig. 4C), suggesting that activation of HO system attenuates the NADPHox-dependent activation of VSMC induced by heme.",
      "key": "d33730941a1c08d31c0ccf826ed96726",
      "line": 173,
      "relation": "decreases",
      "source": 11,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Fig. 4 shows that the inhibition of HO activity by both, SnPP (Fig. 4A) or ZnPP (Fig. 4B), potentiates the effect of heme on VSMC proliferation.",
      "key": "5263c4590383584c8edd04ec868de50f",
      "line": 163,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Additionally, it was observed that inhibition of HO-1 by ZnPP induced a further increase in hemeinduced ROS production (Fig. 4C), suggesting that activation of HO system attenuates the NADPHox-dependent activation of VSMC induced by heme.",
      "key": "b8c343d0edc16aab5497590260422141",
      "line": 172,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "neutrophil": true
        },
        "Concentration": {
          "10 mM": true
        },
        "MeSHAnatomy": {
          "Muscle, Smooth, Vascular": true
        },
        "TextLocation": {
          "Results": true
        },
        "TimePoint": {
          "60 min": true
        }
      },
      "citation": {
        "authors": [
          "Arruda MA",
          "Assreuy J",
          "Barcellos-de-Souza P",
          "Barja-Fidalgo C",
          "Moraes JA",
          "Nascimento-Silva V",
          "Rodrigues G",
          "Silva SV"
        ],
        "date": "2012-10-01",
        "db": "PubMed",
        "db_id": "22954673",
        "db_name": "Atherosclerosis",
        "first": "Moraes JA",
        "last": "Barja-Fidalgo C",
        "pages": "394-400",
        "volume": "224"
      },
      "evidence": "Fig. 4 shows that the inhibition of HO activity by both, SnPP (Fig. 4A) or ZnPP (Fig. 4B), potentiates the effect of heme on VSMC proliferation.",
      "key": "6c05f3a86d8b8bb87693dfce09ae6224",
      "line": 164,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 11
    },
    {
      "key": "eed4d9de6503a1a4413d930ab3b20061",
      "relation": "partOf",
      "source": 1,
      "target": 10
    },
    {
      "key": "8f2fc1f535ae6cea7c829a25cff96330",
      "relation": "partOf",
      "source": 6,
      "target": 10
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"2-(2-amino-3-methoxyphenyl)chromen-4-one\")",
      "concept": {
        "name": "2-(2-amino-3-methoxyphenyl)chromen-4-one",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3b127fbd9e1fe21d7cc38dd2dce72b26"
    },
    {
      "bel": "a(CHEBI:\"tin atom\")",
      "concept": {
        "name": "tin atom",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "bcae29b8b98e8ecb78319dfee6c571ab"
    },
    {
      "bel": "a(CHEBI:\"zinc protoporphyrin\")",
      "concept": {
        "name": "zinc protoporphyrin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "84a29b132d7586c327789b31bd5f806c"
    },
    {
      "bel": "a(CHEBI:Trolox)",
      "concept": {
        "name": "Trolox",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "a570b2d17af9f4d9d6591c1cc692d831"
    },
    {
      "bel": "a(CHEBI:dibenziodolium)",
      "concept": {
        "name": "dibenziodolium",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e43f436e231cfa0bebcdf692a4016c7f"
    },
    {
      "bel": "a(CHEBI:heme)",
      "concept": {
        "name": "heme",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "784587e400a7972b75c28341c34a7ccc"
    },
    {
      "bel": "a(CHEBI:protoporphyrin)",
      "concept": {
        "name": "protoporphyrin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1bf94d257510d706cb369fb31c320914"
    },
    {
      "bel": "a(MESH:\"Reactive Oxygen Species\")",
      "concept": {
        "name": "Reactive Oxygen Species",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "dd0e798c738472fa8ffb9fa88a2eacc7"
    },
    {
      "bel": "bp(GO:\"cell migration\")",
      "concept": {
        "name": "cell migration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "26a5af4491116059185aaf203742481a"
    },
    {
      "bel": "bp(GO:\"cell proliferation\")",
      "concept": {
        "name": "cell proliferation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "aeefbf956f4e291c9a00e6cf4d6d43b9"
    },
    {
      "bel": "complex(a(CHEBI:\"tin atom\"), a(CHEBI:protoporphyrin))",
      "function": "Complex",
      "id": "d5559a0982f45e05855760984bcecadb",
      "members": [
        {
          "bel": "a(CHEBI:\"tin atom\")",
          "concept": {
            "name": "tin atom",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "bcae29b8b98e8ecb78319dfee6c571ab"
        },
        {
          "bel": "a(CHEBI:protoporphyrin)",
          "concept": {
            "name": "protoporphyrin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "1bf94d257510d706cb369fb31c320914"
        }
      ]
    },
    {
      "bel": "p(RGD:Hmox1)",
      "concept": {
        "name": "Hmox1",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "734d638e1da7b9ecd827cb9fc371cb60"
    },
    {
      "bel": "p(RGD:Mapk1)",
      "concept": {
        "name": "Mapk1",
        "namespace": "RGD"
      },
      "function": "Protein",
      "id": "bdd35d9c56497f5abe78f885c72591c2"
    }
  ]
}